SCHEMBL19212420

SCHEMBL19212420

CC(C)(C)OC(=O)N1CCC(c2ccc(CC#N)cc2Cl)CC1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.54
STS P08842 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
THRB P10828 1/20 0.45
TP53 P04637 2/20 0.45
CNR1 P21554 1/20 0.43
POLB P06746 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NR1H2 P55055 1/20 0.41
USP2 O75604 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29707387 1.00 GPR119 (0.54) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL19212180 0.87 GPR119 (0.51) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL29707348 0.87 GPR119 (0.51) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL28697178 0.87 GPR119 (0.49) GPR119STSMAPTTP53CNR1
SCHEMBL19212385 0.84 STS (0.46) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL29707368 0.84 STS (0.46) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL17825455 0.82 GPR119 (0.62) GPR119SMN1; SMN2MAPTKDM4ETHRB
SCHEMBL4786221 0.82 CNR1 (0.56) STSSMN1; SMN2MAPTKDM4ETHRB
SCHEMBL28673691 0.81 GPR119 (0.49) GPR119STSSMN1; SMN2MAPTKDM4E
SCHEMBL17398495 0.81 ESR2 (0.52) GPR119STSSMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071560-B Thienopyridine carboxamides as ubiquitin-specific protease inhibitors 瓦洛健康公司 2022-01-14 CN disclosed
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed